2967 Utilisation of high efficacy therapy for managing multiple sclerosis in Australia

• Helmut Butzkueven,
• Simon Broadley,
• Martin Merschhemke,
• Nicholas Riley,
• Michael Barnett,
• Anneke Van Der Walt,
• Pamela McCombe,
• Rob Walker,
• Nicholas Adlard,
• Naomi Burke,
• Imtiaz Samjoo

Affiliations

Helmut Butzkueven

Clinical Neurosciences, Alfred Health, Melbourne, Victoria, Australia

Simon Broadley

5School of Medicine, Gold Coast Campus, Griffith University, Gold Coast, QLD, Australia

Martin Merschhemke

10 Neuroscience Development Unit, Novartis Pharma AG, Basel, Switzerland

Nicholas Riley

Department of Hand Surgery, Oxford University Hospitals NHS Foundation Trust, Nuffield Orthopaedic Centre, Oxford, UK

Michael Barnett

1Royal Prince Alfred Hospital, Camperdown, NSW, Australia

Anneke Van Der Walt

3Department of Neurosciences, Monash University, Prahran, VIC, Australia

Pamela McCombe

18Royal Brisbane and Women’s Hospital, Herston, QLD, Australia

Rob Walker

20Novartis Pharmaceuticals Australia Pty Ltd, Macquarie Park, NSW, Australia

Nicholas Adlard

6 Novartis, Frimley

Naomi Burke

1Novartis, North Ryde, NSW, Australia

Imtiaz Samjoo

5Eversana, Burlington, Ontario, Canada